Upon taking office, President Joe Biden quickly released a national strategy to deal with COVID-19. That plan included the continued use of the Defense Production Act for expanding the manufacturing and purchasing of vaccines and other coronavirus-related items.
The act, which dates from the Truman administration, has been brought up a lot lately as the United States tries to get its arms around the coronavirus pandemic. Analysts familiar with Pentagon contracting and DPA authorities say they expect the Biden administration to ramp up its use much more in the coming year.
“There were significant DPA actions that happened in the past year under former President Trump, although they tailed off after